AFP and hepatocellular carcinoma: AFP is a biomarker widely used to diagnose HCC [34] and has even proven useful as a marker for predicting intrahepatic recurrence and extrahepatic metastasis [35], [36] and evaluating antitumor response after radiofrequency ablation [37] and sorafenib therapy [38].